Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Non-cash Items: 2017-2022

  • Arcus Biosciences' Non-cash Items fell 80.29% to $50.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $50.0 million, marking a year-over-year decrease of 80.29%. This contributed to the annual value of $50.0 million for FY2022, which is 869.32% up from last year.
  • Latest data reveals that Arcus Biosciences reported Non-cash Items of $50.0 million as of Q4 2022, which was down 80.29% from $253.6 million recorded in Q4 2021.
  • In the past 5 years, Arcus Biosciences' Non-cash Items registered a high of $253.6 million during Q4 2021, and its lowest value of $238,721 during Q4 2018.
  • Its 3-year average for Non-cash Items is $142.0 million, with a median of $122.2 million in 2020.
  • In the last 5 years, Arcus Biosciences' Non-cash Items crashed by 87.44% in 2018 and then surged by 10,572.46% in 2020.
  • Over the past 5 years, Arcus Biosciences' Non-cash Items (Quarterly) stood at $238,721 in 2018, then soared by 379.77% to $1.1 million in 2019, then soared by 10,572.46% to $122.2 million in 2020, then surged by 107.49% to $253.6 million in 2021, then tumbled by 80.29% to $50.0 million in 2022.
  • Its last three reported values are $50.0 million in Q4 2022, $253.6 million for Q4 2021, and $122.2 million during Q4 2020.